Journal of Diagnostics Concepts & Practice ›› 2017, Vol. 16 ›› Issue (02): 166-170.doi: 10.16150/j.1671-2870.2017.02.009
• Original articles • Previous Articles Next Articles
QIAO Changting, LI Lei, WU Anni, YUAN Fei
Received:
2016-12-27
Online:
2017-04-25
Published:
2017-04-25
CLC Number:
QIAO Changting, LI Lei, WU Anni, YUAN Fei. Relationship between HER2 expression and clinicopathological features in advanced gastric cancer[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(02): 166-170.
[1] Torre LA, Bray F, Siegel RL, et al.Global cancer statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108. [2] Zhao P, Dai M, Chen W, et al.Cancer trends in China[J]. Jpn J Clin Oncol,2010,40(4):281-285. [3] Wagner AD, Grothe W, Haerting J, et al.Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data[J]. J Clin Oncol,2006,24(18):2903-2909. [4] Bang YJ, Van Cutsem E, Feyereislova A, et al.Trastuzumab in combination with chemotherapy [5] Tai W, Mahato R, Cheng K.The role of HER2 in cancer therapy and targeted drug delivery[J]. J Control Release,2010,146(3):264-275. [6] Kaur A, Dasanu CA.Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma[J]. Expert Opin Pharmacother,2011,12(16):2493-2503. [7] Lambein K, Praet M, Forsyth R, et al.Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: bio-logical and methodological considerations[J]. J Clin Pathol,2011,64(3):200-207. [8] Li Q, Wang D, Li J, et al.Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas[J]. BMC Cancer,2011,11:277. [9] Yan B, Choo SN, Mulyadi P, et al.Dual-colour HER2/chromosome 17 chromogenic [10] Reichelt U, Duesedau P, Tsourlakis MCh, et al.Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus[J]. Mod Pathol,2007,20(1):120-129. [11] Yan B, Yau EX, Choo SN, et al.Dual-colour HER2/chromosome 17 chromogenic [12] Jørgensen JT, Hersom M.HER2 as a prognostic marker in gastric cancer-A cystematic analysis of data from the literature[J]. J Cancer,2012,3:137-144. [13] Nagatsuma AK, Aizawa M, Kuwata T, et al. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma[J]. Gastric Cancer,2015 Apr,18(2):227-238. [14] Carpenter G, Cohen S.Epidermal growth factor[J]. J Biol Chem,1990,265(14):7709-7712. [15] Oda K, Matsuoka Y, Funahashi A, et al.A comprehensive pathway map of epidermal growth factor receptor signaling[J]. Mol Syst Biol,2005,1:2005. [16] Normanno N, Bianco C, Strizzi L, et al. The ErbB receptors and their ligands in cancer: an overview[J]. Curr Drug Targets,2005 May,6(3):243-257. [17] Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3[J]. Nat Rev Cancer,2009 Jul,9(7):463-475. [18] Burstein HJ.The distinctive nature of HER2-positive breast cancers[J]. N Engl J Med,2005,353(16):1652-1654. [19] Gschwind A, Fischer OM, Ullrich A.The discovery of receptor tyrosine kinases: targets for cancer therapy[J]. Nat Rev Cancer,2004,4(5):361-370. [20] Toikkanen S, Helin H, Isola J, et al.Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up[J]. J Clin Oncol,1992,10(7):1044-1048. [21] Park JS, Rha SY, Chung HC, et al.Clinicopathological features and prognostic significance of HER2 expression in gastric cancer[J]. Oncology. 2015;88(3):147-156. [22] Grabsch H, Sivakumar S, Gray S, et al.HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series[J]. Cell Oncol,2010,32(1-2):57-65. |
[1] | YANG Ruixin, DU Yutong, YAN Ranlin, ZHU Zhenggang, LI Chen, YU Yingyan. Improving exploration of biological sample pretreatment in single-cell transcriptome sequencing of gastrointestinal tumors [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 567-574. |
[2] | LI Nana, QI Tao, ZHU Liming. Clinical value of serum pepsinogen,gastrin 17 and Helicobacter pylori IgG antibody in primary screening of gastric diseases [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 509-513. |
[3] | WANG Zhaohui, WU Haibo. Clinicopathological analysis of 31 cases of gastric schwannoma [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 552-556. |
[4] | LI Juan, LIU Jingsong, LI Mei, LI Dianwei, ZHU Hong. Bronchiolar adenoma: a clinic pathological analysis of 10 cases and review of literature [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(05): 466-470. |
[5] | WEI Ruoqu, YU Hong, YAO Zhirong. Fibroblastic connective tissue nevus in children: a case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 190-194. |
[6] | YANG Cuiping, YANG Xiaojin, YANG Yanpin, ZHANG Mengyin, XIE Ling, YU Xiaojun, CAI Boer, CHEN Dengyu, CHEN Ping, WU Yunlin. Functional study and detection of vimentin produced by miR-200c target gene in human gastric cancer BGC823 cells [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 414-419. |
[7] | MENG Leijun, ZHANG Jing, WANG Xueli, LI Zhi, ZHANG Hong, ZENG Naiyan. Identification of differentially expressed target genes in pediatric Burkitt lymphoma and its clinical application [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 248-257. |
[8] | JIN Jiaoying, LI Qianyu, JIANG Hongwei, HAN Dongyan, XI Hao, WEI Qing. Report of a case of composite pheochromocytoma and review of literature [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 165-169. |
[9] | HE Yanyan, FENG Lijin, WEI Qing. Pleomorphic giant cell adenocarcinoma of prostate: clinicopathological analysis of a case and review of literature [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 160-164. |
[10] | WANG Shunli, DENG Shuangshuang, GAO Hui, XIAO Tianyu, GAO Jinli. Analysis of clinicopathological characteristics of breast encapsulated papillarycarcinoma [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 89-92. |
[11] | JIANG Jiang, ZENG Zhikun, SHI Bowen, PAN Zhaocheng, YAN Ling, WANG Yujie, ZHANG Huan. Study on motion characteristics of gastric cancer cells using glassy dynamics analysis [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 645-648. |
[12] | ZHOU Lei, WANG Hong, XU Huiming, YE Tao, GAO Jianping, SUN Yijun, XIE Jun. The potential value of serum pepsinogen in screening of chronic atrophic gastritis among population with high risk for gastric cancer of Shanghai central urban area [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 570-574. |
[13] | WANG Lan, ZHANG Huan, GE Yingqian, LU Jing, CUI Zheng, YAN Ling, PAN Zilai. Clinical application and evaluation of artificial intelligence-assisted semi-automatic segmentation software for detection of liver metastases from gastric cancer: intra-observer and inter-observer differences [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 515-520. |
[14] | YAO Jiejie, ZHU Ying, ZHAN Weiwei, CHEN Xiaosong, FEI Xiaochun. Correlation of sonographic features of non-mass ductal carcinoma in situ with clinicopathological findings and biomarkers [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 676-681. |
[15] | HAN Dongyan, FU Huijun, HE Yanyan, XI Hao, WEI Qing. Endolymphatic sac tumor: Clinicopathological features and review of literature [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 711-714. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||